These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 964711)

  • 1. [Activation of the immune system and remission period in malignant lymphomas].
    Havemann K; Schultz H
    Hamatol Bluttransfus; 1976; 18():329-38. PubMed ID: 964711
    [No Abstract]   [Full Text] [Related]  

  • 2. Delay in progression of malignant lymphoma after BCG vaccination.
    Sokal JE; Aungst CW; Snyderman M
    N Engl J Med; 1974 Dec; 291(23):1226-30. PubMed ID: 4609380
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immune responses and prognosis in malignant lymphomas.
    Sokal JE; Aungst CW
    Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
    [No Abstract]   [Full Text] [Related]  

  • 4. Vinblastine treatment of malignant lymphomas.
    Klener P; Donner L; Neuwirtová R; Ort J
    Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of vinblastine for maintenance therapy in malignant lymphomas.
    Klener P; Donner L; Ort J
    Neoplasma; 1974; 21(3):323-9. PubMed ID: 4608740
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant chemotherapy in malignant lymphomas].
    Obrecht JP
    Haematol Blood Transfus; 1978; 22():89-100. PubMed ID: 374201
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of BCG or levamisole as an adjunct to chemotherapy or radiotherapy in malignant lymphomas.
    Advani SH; Gangal SG; Gopal R; Nair CN; Dinshaw KA; Desai PB
    Indian J Med Res; 1985 Mar; 81():306-12. PubMed ID: 4018861
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination chemotherapy in malignant lymphoma. Results of long-term follow-up].
    Kimura I; Ohnoshi T; Ueoka H; Nishihara R
    Rinsho Ketsueki; 1985 Jun; 26(6):831-40. PubMed ID: 4068248
    [No Abstract]   [Full Text] [Related]  

  • 9. Complex radiation-chemotherapy of malignant lymphomas in combination with nonspecific BCG-immunostimulation. A preliminary report.
    Marinov L
    Panminerva Med; 1976; 18(5-6):162-6. PubMed ID: 1264470
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunity, leukemias and lymphomas. 3. Immune reactions in malignant granuloma in relationship to the clinical stage of the disease].
    Danieli G; Malini PL; Montroni M; Cremonini G; Lauria F; Tura S
    G Clin Med; 1972 Apr; 53(4):179-95. PubMed ID: 4651225
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune deficiency in malignant lymphomas.
    Konopka L; Pawelski S; Maślanka K; Zupańska B; Cieśluk S
    Chemioterapia; 1987 Jun; 6(2 Suppl):745-8. PubMed ID: 3509538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
    Viollier AF; Senn HJ
    Schweiz Med Wochenschr; 1976 May; 106(22):730-42. PubMed ID: 996491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy in lymphoma.
    Alexanian R
    Arch Intern Med; 1975 Jan; 135(1):62-6. PubMed ID: 1089397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCG vaccination in the treatment of malignant non-Hodgkin lymphomas].
    Gociu M; Ciocoiu A; Moţoiu I; Drăghici D; Dumitrescu A; Costescu M; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):25-8. PubMed ID: 6145202
    [No Abstract]   [Full Text] [Related]  

  • 16. [The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
    Höche D; Fink R; Anger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):13-26. PubMed ID: 6157615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant lymphomas at the Pathology Department, University of Khartoum, Sudan.
    Ahmed MA; Omer A; el Hassn AM
    East Afr Med J; 1984 Aug; 61(8):627-31. PubMed ID: 6336041
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification of malignant lymphomas and the relationship between histopathological aspects and clinical course].
    van Unnik JA; Somers R
    Ned Tijdschr Geneeskd; 1975 Jun; 119(25):981-7. PubMed ID: 1143584
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.